USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY

摘要

The invention relates to the use of cannabidiol (CBD), at a dose of greater than 300mg/day, in combination with a standard anti-epileptic drug (SAED) which acts via sodium or calcium channels, for use in the treatment of epilepsy. The SAED is preferably one which• modifies low-threshold or transient neuronal calcium currents, or• reduces high-frequency neuronal firing and sodium-dependent action potentials and enhances GABA effects.;Preferred SAED's are ethosuximide and valproate.